Literature DB >> 11819242

Current status of gene therapy in gastroenterology.

Chang-Tai Xu, Bo-Rong Pan.   

Abstract

Year:  1998        PMID: 11819242      PMCID: PMC4767776          DOI: 10.3748/wjg.v4.i1.85

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  11 in total

1.  Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma.

Authors:  D Amadori; M Maltoni; A Volpi; O Nanni; E Scarpi; B Renault; N S Pellegata; M Gaudio; E Magni; G N Ranzani
Journal:  Cancer       Date:  1997-01-15       Impact factor: 6.860

Review 2.  Gene replacement strategies for the prevention and therapy of cancer.

Authors:  J A Roth; T Mukhopadhyay; W W Zhang; T Fujiwara; R Georges
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

3.  p53 expression in Barrett's oesophagus, dysplasia, and adenocarcinoma using antibody DO-7.

Authors:  P J Symmans; J M Linehan; M J Brito; M I Filipe
Journal:  J Pathol       Date:  1994-07       Impact factor: 7.996

4.  Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides.

Authors:  G Y Wu; C H Wu
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

5.  Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery.

Authors:  C A Westbrook; S J Chmura; R B Arenas; S Y Kim; G Otto
Journal:  Hum Mol Genet       Date:  1994-11       Impact factor: 6.150

6.  Correcting the PiZ defect in the alpha 1-antitrypsin gene of human cells by targeted homologous recombination.

Authors:  E Savransky; P Hytiroglou; N Harpaz; S N Thung; E M Johnson
Journal:  Lab Invest       Date:  1994-05       Impact factor: 5.662

7.  Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

Authors:  B E Huber; E A Austin; C A Richards; S T Davis; S S Good
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

8.  Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.

Authors:  N J Caplen; E W Alton; P G Middleton; J R Dorin; B J Stevenson; X Gao; S R Durham; P K Jeffery; M E Hodson; C Coutelle
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

9.  Gene therapy for cancer using tumour-specific prodrug activation.

Authors:  J D Harris; A A Gutierrez; H C Hurst; K Sikora; N R Lemoine
Journal:  Gene Ther       Date:  1994-05       Impact factor: 5.250

10.  The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.

Authors:  T L Burgess; E F Fisher; S L Ross; J V Bready; Y X Qian; L A Bayewitch; A M Cohen; C J Herrera; S S Hu; T B Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

View more
  10 in total

1.  Molecular biology and the diagnosis and treatment of liver diseases.

Authors:  Howard J Worman; Lin Feng; Naoto Mamiya
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

Review 2.  Current gene therapy for stomach carcinoma.

Authors:  C T Xu; L T Huang; B R Pan
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma.

Authors:  D H Liu; X Y Zhang; D M Fan; Y X Huang; J S Zhang; W Q Huang; Y Q Zhang; Q S Huang; W Y Ma; Y B Chai; M Jin
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Glyco-poly-l-lysine is better than liposomal delivery of exogenous genes to rat of liver.

Authors:  Chang-Qing Yang; Ji-Yao Wang; Bo-Ming He; Jian-Jun Liu; Jin-Sheng Guo
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

5.  Antisense to cyclin D1 reverses the transformed phenotype of human gastric cancer cells.

Authors:  Bing Chen; Xue-Yong Zhang; Yu-Jing Zhang; Ping Zhou; Yan Gu; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

6.  Adenoviral gene therapy in hepatocellular carcinoma: a review.

Authors:  Iván Lyra-González; Laura Esther Flores-Fong; Ignacio González-García; David Medina-Preciado; Juan Armendáriz-Borunda
Journal:  Hepatol Int       Date:  2012-04-25       Impact factor: 6.047

7.  Significance of changes of gastrointestinal peptides in blood and ileum of experimental spleen deficiency rats.

Authors:  Li-Sheng Li; Rui-Yao Qu; Wei Wang; Hua Guo
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

8.  A novel HBV antisense RNA gene delivery system targeting hepatocellular carcinoma.

Authors:  Chun-Hong Ma; Wen-Sheng Sun; Pei-Kun Tian; Li-Fen Gao; Su-Xia Liu; Xiao-Yan Wang; Li-Ning Zhang; Ying-Lin Cao; Li-Hui Han; Xiao-Hong Liang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

Review 9.  Adenoviral gene therapy in gastric cancer: a review.

Authors:  Nima Khalighinejad; Hesammodin Hariri; Omid Behnamfar; Arash Yousefi; Amir Momeni
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

10.  Construction of a novel vector expressing the fusion suicide gene yCDglyTK and hTERT-shRNA and its antitumor effects.

Authors:  Jia Li; Guiying Zhang; Ting Liu; Huan Gu; Lu Yan; Bolin Chen
Journal:  Exp Ther Med       Date:  2012-06-18       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.